BLACKROCK SMALLER COMPANIES TRUST PLC
All information is at 31 DECEMBER 2011 and unaudited.
Performance at month end is calculated on a capital only basis
One Three One Three Five
Month Months Year Years Years
Net asset value -0.5% 2.1% -11.3% 137.1% 21.6%
Share price 0.8% -3.0% -14.4% 135.5% 15.0%
HGSC ex Inv Trust + AIM* -1.9% 0.2% -15.0% 71.9% -23.2%
Sources: BlackRock and Datastream
*With effect from 1 September 2007 the Hoare Govett Smaller Companies plus AIM
(ex Investment Companies) Index replaced the FTSE SmallCap Index (ex Investment
Companies) as the Company's benchmark. For the five year period the above
index has been blended to reflect this.
At month end
Net asset value Capital only (debt at par value): 525.96p
Net asset value Capital only (debt at fair value): 521.75p
Net asset value incl. Income (debt at par value): 532.79p**
Net asset value incl. Income (debt at fair value): 528.58p**
Share price: 427.38p
Discount to cum income NAV (debt at par value): 19.8%
Discount to cum income NAV (debt at fair value): 19.1%
Net yield: 1.7%
Total assets: £272.3m^
Gearing incl. Income (debt at fair value): 7.1%
Ordinary shares in issue: 47,879,792^^
**includes net revenue of 6.83p
^includes current year revenue
^^excludes 2,113,731 shares held in treasury
Ten Largest Sector
Weightings % of total assets
Support Services 9.8
Software & Computer Services 9.3
Electronic & Electrical Equipment 8.4
Oil & Gas Producers 7.5
Industrial Metals & Mining 6.6
Financial Services 6.1
Household Goods & Home Construction 5.9
Media 5.6
Pharmaceuticals & Biotechnology 4.7
Industrial Engineering 4.7
----
Total 68.6
====
Ten Largest Equity Investments (in alphabetical order)
Company
Alternative Networks
Aveva Group
Bellway
Fenner
Fidessa group
Hargreaves Services
ITE Group
Oxford Instruments
Senior
Spirax-Sarco Engineering
Commenting on the markets, Mike Prentis, representing the Investment Manager
noted:
During December the NAV on a capital only basis fell by 0.5%; the benchmark
fell by 1.9%. The FTSE 100 Index fell by 1.2% during the month.
Outperformance was entirely derived from stock selection, with a slight
negative contribution from sector allocation.
From a stock selection point of view our biggest positive contributor was
Collins Stewart, which announced a takeover from Canaccord at a significant
premium. Another holding, Jacques Vert, was also taken over during the month at
a good premium. No holding significantly detracted from relative performance.
Other than the holdings mentioned above, newsflow from the portfolio was
generally good during December.
Activity in the month was limited although we decided to re-introduce Hunting
into the portfolio. It has made several acquisitions recently and these add
significantly to its product range.
18 January 2012
ENDS
Latest information is available by typing www.blackrock.co.uk/brsc on the
internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV
terminal). Neither the contents of the Manager's website nor the contents of
any website accessible from hyperlinks on the Manager's website (or any other
website) is incorporated into, or forms part of, this announcement.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.